Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-hispanic white women: The Ovarian Cancer Association Consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 2, 2010, Pages 600-604

  Phelan, Catherine M ^a   Tsai, Ya Yu ^a   Goode, Ellen L ^b   Vierkant, Robert A ^b   Fridley, Brooke L ^b   Beesley, Jonathan ^c   Chen, Xiao Qing ^c   Webb, Penelope M ^c   Chanock, Stephen ^e   Cramer, Daniel W ^f   Moysich, Kirsten ^g   Edwards, Robert P ^h   Chang Claude, Jenny ⁱ   Garcia Closas, Montserrat ^e   Yang, Hannah ^e   Wang Gohrke, Shan ^j   Hein, Rebecca ⁱ   Green, Adele C ^c   Lissowska, Jolanta ^k   Carney, Michael E ^l   Lurie, Galina ^l   Wilkens, Lynne R ^l   Ness, Roberta B ^m   Pearce, Celeste Leigh ⁿ   Wu, Anna H ⁿ   Van Den Berg, David J ⁿ   Stram, Daniel O ⁿ   Terry, Kathryn L ⁿ   Whiteman, David C ^c   Whittemore, Alice S ^o   DiCioccio, Richard A ^g   McGuire, Valerie ^o   Doherty, Jennifer A ^p   Rossing, Mary Anne ^p   Anton Culver, Hoda ^q   Ziogas, Argyrios ^q   Hogdall, Claus ^r   Hogdall, Estrid ^s   Kjaer, Susanne Krüger ^s   Blaakaer, Jan ^s   Quaye, Lydia ^t   Ramus, Susan J ^t   Jacobs, Ian ^t   Song, Honglin ^u   Pharoah, Paul D P ^u   Iversen, Edwin S ^d,v   Marks, Jeffrey R ^w   Pike, Malcolm C ⁿ   Gayther, Simon A ^t   Cunningham, Julie M ^b   Goodman, Marc T ^l   Schildkraut, Joellen M ^w   Chenevix Trench, Georgia ^c   Berchuck, Andrew ^w   Sellers, Thomas A ^a   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Mayo Clinic   (United States)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e NATIONAL CANCER INSTITUTE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j UNIVERSITY OF ULM   (Germany)

^k INSTITUTE OF ONCOLOGY   (Poland)

^l UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^m UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p Fred Hutchinson Cancer Research Center   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF COPENHAGEN   (Denmark)

^s INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^t UNIVERSITY COLLEGE LONDON   (United Kingdom)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v Duke University   (United States)

^w DUKE CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLGALACTOSAMINYLTRANSFERASE; URIDINE DIPHOSPHATE N ACETYLGALACTOSAMINE;

ADULT; AGED; ARTICLE; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; FEMALE; GALNT1 GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 76149143756     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0861     Document Type: Article

References (18)

1. Bennett EP, Weghuis DO, Merkx G, van Kessel AG, Eiberg H, Clausen H.Genomic organization and chromosomal localization of three members of the UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase family. Glycobiology 1998;8: 547-55.
2. Hanisch FG. O-glycosylation of the mucin type. Biol Chem 2001;382: 143-9.
3. Li B, An HJ, Kirmiz C, Lebrilla CB, Lam KS, Miyamoto S. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. J Proteome Res 2008;7:3776-88, Epub 2008 Jul 22.
4. Sellers TA, Huang Y, Cunningham J, et al. Association of SNPs in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:397-404.
5. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
6. Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Adv Exp Med Biol 2008;622:53-67.
7. Pearce CL, Near AM, Van Den Berg DJ, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 2009;100:412-20, Epub 2009 Jan 6.
8. Palmieri RT, Wilson MA, Iversen ES, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008;17:3567-72.
9. Ramus SJ, Vierkant RA, Johnatty SE, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008;123:380-8.
10. Pearce CL, Wu AH, Gayther SA, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer 2008;98:282-8, Epub 2008 Jan 22.
11. Gayther SA, Song H, Ramus SJ, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007;67:3027-35.
12. Garcýa-Closas M, Brinton LA, Lissowska J, et al. Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer 2007;7:60.
13. Pearce CL, Hirschhorn JN, Wu AH, et al. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 2005;97:51-9.
14. Quaye L, Dafou D, Ramus SJ, et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 2009;18: 1869-78.
15. Schildkraut JM, Goode EL, Clyde MA, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009;69:2349-57, Epub 2009 Mar 10.
16. Song H, Ramus SJ, Krüger Kjaer S, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 2009.
17. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75, Epub 2007 Jul 25.
18. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.